Save information for later
Sign Up

Learn About Hormone Replacement Therapy (HRT)

What is the definition of Hormone Replacement Therapy (HRT)?
Hormone replacement therapy is the use of the hormones estrogen and progesterone that are used to replace natural hormones that the body stops producing after menopause. Hormone replacement therapy helps to treat symptoms of menopause such as hot flashes and vaginal dryness. Hormone replacement therapy can be administered in many different forms, such as a pill, gel, cream, spray, skin patch, or vaginal ring.
What are the symptoms of Hormone Replacement Therapy (HRT)?
Symptoms that hormone replacement therapy treats include hot flashes, night sweats, pain during sex, and vaginal dryness.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hormone Replacement Therapy (HRT)?
Hormone replacement therapy is usually a combination of estrogen and progesterone.
Who are the top Hormone Replacement Therapy (HRT) Local Doctors?
Elite in Hormone Replacement Therapy (HRT)
Obstetrics and Gynecology
Elite in Hormone Replacement Therapy (HRT)
Obstetrics and Gynecology

University Of Virginia Physicians Group

2955 Ivy Rd, Suite 104, 
Charlottesville, VA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Joann Pinkerton is an Obstetrics and Gynecologist in Charlottesville, Virginia. Dr. Pinkerton and is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Postmenopausal Osteoporosis, Melorheostosis, Melorheostosis with Osteopoikilosis, and Hormone Replacement Therapy (HRT). Dr. Pinkerton is currently accepting new patients.

Joann E. Manson
Elite in Hormone Replacement Therapy (HRT)
Internal Medicine
Elite in Hormone Replacement Therapy (HRT)
Internal Medicine
Boston, MA 
Languages Spoken:
English

Joann Manson is an Internal Medicine provider in Boston, Massachusetts. Dr. Manson and is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Type 2 Diabetes (T2D), Coronary Heart Disease, Hormone Replacement Therapy (HRT), and Tubal Ligation.

 
 
 
 
Learn about our expert tiers
Learn More
Andrew M. Kaunitz
Elite in Hormone Replacement Therapy (HRT)
Obstetrics and Gynecology
Elite in Hormone Replacement Therapy (HRT)
Obstetrics and Gynecology

University Of Florida Jacksonville Physicians, Inc.

655 W 8th St, 
Jacksonville, FL 
Languages Spoken:
English
Accepting New Patients

Andrew Kaunitz is an Obstetrics and Gynecologist in Jacksonville, Florida. Dr. Kaunitz and is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Menopause, Menorrhagia, Newborn Low Blood Sugar, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion. Dr. Kaunitz is currently accepting new patients.

What are the latest Hormone Replacement Therapy (HRT) Clinical Trials?
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency

Background: Premature ovarian insufficiency (POI) is a condition in which women under the age of 40 years have absent or irregular menstrual cycles. POI can cause infertility, signs of menopause, osteoporosis, and other symptoms. Hormone replacement therapy (HRT) is a treatment that gives women extra hormones, such as estrogen and progesterone. HRT works well in adult women. Researchers want to find the most ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
MK-5684-004: A Phase 3, Randomized, Open-label Study of Opevesostat Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA) (OMAHA-004)

Summary: The purpose of this study is to assess the efficacy and safety of opevesostat plus hormone replacement therapy (HRT) compared to alternative abiraterone acetate or enzalutamide in participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) previously treated with one next-generation hormonal agent (NHA). The primary study hypotheses are that opevesostat is superior to alternative abi...